On Demand Neuropsychiatric Workshop Series: Neuropsychiatric Aspects of COVID-19
This presentation was originally reviewed on May 24, 2022, and broadcast live online on May 20, 2022, from 1:00 PM - 4:15 PM ET.
The views and opinions expressed by this presenter in this lecture are their own, and do not represent the views of Sheppard Pratt.
The current COVID-19 pandemic has been transformative for medicine and society. This is also reflected in the unprecedented volume of COVID-relevant papers on every subject of life sciences and humanities. A multitude of neurological and psychiatric problems and illnesses have been associated, in one way or another, with COVID-19. Much research is still in the early phase, but some patterns being to emerge. Because of the spread of infection and the commonality of neuropsychiatric complaints, the neurological and psychiatric practitioner will inevitably deal with problems or questions linking the virus with behavioral, cognitive, and mental complaints. This CME activity will provide a general framework within which such problems can be understood and managed, while awaiting more definitive information from ongoing research.
This activity is intended for physicians, nurses, psychologists, social workers, counselors, and other mental health professionals.
After this lecture, registrants will be able to:
- Define potential neurological causes of mental, behavioral, and cognitive impairments related to COVID-19
- Explain psychological and psychiatric issues associated with COVID-19, in the acute and chronic phase, for patients and others
- Discuss the interaction among neurological/medical, psychiatric and pharmacological issues in the context of COVID-19
There is no commercial support for this activity.
About The Speaker
Dr. Vassilis E. Koliatsos is the senior neuropsychiatrist for Research and Education and the Stulman Scholar in Clinical Neuropsychiatry at Sheppard Pratt. Dr. Koliatsos, who is also professor in Psychiatry, Neurology, and Neuropathology at the Johns Hopkins University School of Medicine and Clinical Professor of Psychiatry at the University of Maryland School of Medicine, founded the Neuropsychiatry Program at Sheppard Pratt in 1997 to establish a coordinated approach to care for a variety of complex patients with severe cognitive, emotional, and behavioral problems across life cycle, from development to advanced age. With generous funding from the Stulman foundation, the Women’s Hospital Foundation, and other grateful patient families, the Neuropsychiatry Program was designed to help clarify the causes and mechanisms of symptoms and provides both consultative services and direct patient care. Dr. Koliatsos sees patients in the general neuropsychiatry teaching clinic focusing on general neuropsychiatry, TBI, neurodegenerative dementias, and complex psychopharmacological cases.
Sheppard Pratt holds the standard that its continuing medical education programs should be free of commercial bias and conflict of interest. In accord with Sheppard Pratt's Disclosure Policy, as well as standards of the Accreditation Council for Continuing Medical Education (ACCME) and the American Medical Association (AMA), all planners, reviewers, speakers and persons in control of content have been asked to disclose any relationship he /she (or a partner or spouse) has with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months. All planners, reviewers and speakers have also been asked to disclose any payments accepted for this lecture from any entity besides Sheppard Pratt, and if there will be discussion of any products, services or off-label uses of product(s) during this presentation.
Vassilis E. Koliatsos, MD, reports that he has no relationships with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients during the past 24 months. He will not discuss any products, services, or off-label uses in this presentation.
Event Planners/Reviewers Disclosures: The following event planners and/or reviewers are reported as having no financial interest, arrangement or affiliation with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months: Todd Peters, MD, Deepak Prabhakar, MD, Briana Riemer, MD, Louis Marino, MD, Ehsan Syed, MD, Devi Bhuyan, PhD, Faith Dickerson, PhD, Carrie Etheridge, LCSW-C, Tom Flis, LCPC, Laura Webb, RN-BC, MSN, Bruce Boxer, PhD, MBA, MA, MSN, RN, NPD-BC, NEA-BC, MCHES, CPHQ, Stacey Garnett, RN, MSN, Heather Billings, RN, Lisa Illum, MLIS, MEd, and Jennifer Tornabene.
Physician Statement: Sheppard Pratt is accredited by The Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Sheppard Pratt takes responsibility for the content, quality, and scientific integrity of this CME activity. Sheppard Pratt designates this enduring activity for a maximum of 2.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurse Statement: Sheppard Pratt is approved as a provider of nursing continuing professional development by the Maryland Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Sheppard Pratt takes responsibility for the content, quality, and scientific integrity of this CME activity. This activity provides 2.5 contact hours for nurses.
Psychologist Statement: Sheppard Pratt is authorized by the State Board of Examiners of Psychologists as a sponsor of continuing education. Sheppard Pratt takes responsibility for the content, quality, and scientific integrity of this continuing education activity. Sheppard Pratt designates this educational activity for a maximum of 2.5 contact hours for Psychologists.
Social Worker Statement: Sheppard Pratt is authorized by the Board of Social Work Examiners of Maryland to offer continuing education for Social Workers. Sheppard Pratt takes responsibility for the content, quality, and scientific integrity of this continuing education activity. This activity is approved for 2.5 contact hours in Category II credits for Social Workers.
Counselor Statement: Sheppard Pratt has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 5098. Programs that do not qualify for NBCC credit are clearly identified. Sheppard Pratt is solely responsible for all aspects of the program. This activity is available for 2.5 NBCC clock hours.
- 2.50 ACEP NBCC clock hours
- 2.50 AMA PRA Category 1 Credit™
- 2.50 Category II credits for Social Workers
- 2.50 Psychologists
- 2.50 MNA Contact Hours for Nurses
- 2.50 Participation
DEMAND WEBINAR: FOR BEST RESULTS WATCH USING GOOGLE CHROME
Neuropsychiatric Workshop Series: Neuropsychiatric Aspects of COVID-19
Vassilis E. Koliatsos, MD
Senior Neuropsychiatrist- Research and Education
Professor, Psychiatry, Neurology, and Neuropathology
Johns Hopkins University School of Medicine
Originally reviewed May 24, 2022
Originally broadcast live May 20, 2022, from 1:00 pm - 4:15 pm ET
Enduring Activity Credit Expiration Date: June 19, 2024
Activity Time: One hour recorded webinar lecture with a 15-minute evaluation process. Total Time: 2:45
TO EARN CONTINUING EDUCATION CREDIT FOR YOUR ATTENDANCE
On the OVERVIEW or REGISTER/TAKE COURSE tab, select the GREEN RECTANGLE, TAKE COURSE to begin.
The PowerPoint handout will be available for download.
After downloading the handout, select NEXT to begin and watch the video.
You may need to select play for the video to begin.
After the video follow the prompts to complete the evaluation and attestation of credit.
Once you have completed all the components of the Course Progress bar, the certificate will be immediately downloadable.
There is no commercial support for this activity.
Questions? Look at our FAQ’s at https://cme.sheppardpratt.org/content/faq or Email firstname.lastname@example.org
Optimal System Configuration
Flash Player: Adobe Flash Player 10.1+
Browser: Firefox 3+, Internet Explorer 8.0+, Safari 4.0+, or Google Chrome 7.0+
Operating System: Windows XP+ or Mac OS X 10.4+
Internet Connection: 1 Mbps or higher
Windows PC: 500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Sound Card at least 16-bit; Macromedia Flash Player 10 or higher, audio playback with speakers for programs with video content; Firefox 1.1+, Internet Explorer 7.0+, Safari 1.0+, Google Chrome, or Opera
Macintosh: Mac OS X 10.3 or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit